Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Robert Likić

195

Robert

Likić

izv. prof. dr. sc.

Naziv Uloga Akcije
Europska licenca za propisivanje: Priprema budućih liječnika u Europskoj uniji za sigurno propisivanje voditelj na ustanovi
Europska otvorena platforma za edukaciju o propisivanju lijekova voditelj na ustanovi
Razvoj programa Clinical Pharmacology and Therapeutics Teach the Teacher (CP4T). voditelj na ustanovi
Putokaz izlaza iz medicinskih pustinja - poticajne zdravstvene inicijative i politike voditelj na ustanovi
Planetarno zdravstveno obrazovanje u propisivanju lijekova voditelj na ustanovi
Naziv Akcije
Dvorski, Matija; Vitale, Ksenija; Andabaka, Damir; Likić, Robert; Vinković Vrček, Ivana Onečišćenje vode nanočesticama plastike // 27. znanstveno-stručni skup "Voda i javna vodoopskrba". Zagreb: Hrvatski zavod za javno zdravstvo (HZJZ), 2023. str. 140-144
Bakkum, Michiel J. ; Donker, Erik M. ; Spitaleri Timpone, Pietro ; Hagen, Charlotte A. M. ; Richir, Milan C. ; van Agtmael, Michiel A. ; De Ponti, Fabrizio ; Tichelaar, Jelle ; Likic, Robert ; Böttiger, Ylva et al. Educational value of international and intercultural differences in prescribing: the international and interprofessional student-run clinic project // European journal of clinical pharmacology, (2023), 1-4. doi: 10.1007/s00228-023-03465-9
Primorac Padjen, Elena; Marcec, Robert; Zidar, Matija; Padjen, Ivan; Katanec, Tomislav; Anić, Branimir; Likić, Robert Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data. // Rheumatology international, 44 (2023), 2; 273-281. doi: 10.1007/s00296-023-05512-1
Marcec, Robert ; Dodig, Vinko Michael ; Likic, Robert Regdanvimab improves disease mortality and morbidity in patients with COVID-19: Too optimistic and too early to say? // The Journal of infection, 86 (2023), 1; 66-117. doi: 10.1016/j.jinf.2022.10.030
Marcec, Robert ; Dodig, Vinko Michael ; Likic, Robert A meta-analysis regarding fluvoxamine and hospitalization risk of COVID-19 patients: TOGETHER making a difference // The Journal of infection, 86 (2023), 2; 154-225. doi: 10.1016/j.jinf.2022.11.011
Marčec, Robert ; Dodig, Vinko Michael ; Radanović, Igor ; Likić, Robert Intravenous immunoglobulin (IVIg) therapy in hospitalised adult COVID‐19 patients: A systematic review and meta‐analysis // Reviews in medical virology, 32 (2022), 6; e2397, 13. doi: 10.1002/rmv.2397
(EurOP²E consortium) Bakkum, Michiel J. ; Loobeek, Bryan J. ; Richir, Milan C. ; Papaioannidou, Paraskevi ; Likić, Robert ; Sanz, Emilio J. ; Christiaens, Thierry ; Costa, João N. ; Dima, Lorena ; de Ponti, Fabrizio et al. Teaching resources for the European Open Platform for Prescribing Education (EurOP2E)—a nominal group technique study NPJ science of learning, 7 (2022), 1; 23, 7. doi: 10.1038/s41539-022-00141-y
Likić, Robert ; Dear, James W. ; Lewis, Lionel D. Spotlight commentary: Navigating between financial risks and improved treatment outcomes with immune checkpoint inhibitors in cancer patients: The need for biomarker identification and dose optimization // British journal of clinical pharmacology, 88 (2022), 12; 5060-5063. doi: 10.1111/bcp.15548
Marčec, Robert ; Likić, Robert Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients? // Clinical pharmacokinetics, 61 (2022), 9; 1321-1323. doi: 10.1007/s40262-022-01154-x
(EurOP2E consortium) Bakkum, Michiel J. ; Verdonk, Petra ; Thomas, Elias G. ; van Rosse, Floor ; Okorie, Michael ; Papaioannidou, Paraskevi ; Likić, Robert ; Sanz, Emilio J. ; Christiaens, Thierry ; Costa, João N. et al. A Clinical Pharmacology and Therapeutics Teacher's Guide to Race‐Based Medicine, Inclusivity, and Diversity // Clinical pharmacology & therapeutics, 113 (2022), 3; 600-606. doi: 10.1002/cpt.2786
nije evidentirano
nije evidentirano